abstract |
The invention relates to human antibodies that recognize the human C5a receptor. By binding to C5aR, antibodies inhibit C5a signaling, so the pro-inflammatory signal is inhibited. Based on the role of C5a and its receptor in the stimulation of inflammation, the invention also relates to the use of these human anti-C5aR antibodies and in particular in relation to the treatment of immunological disorders. |